Role of Contrast-enhanced Ultrasound in Assessing Indeterminate Renal Lesions and Bosniak ≥2F Complex Renal Cysts Found Incidentally on CT or MRI
Overview
Authors
Affiliations
Objective: To investigate the impact of contrast-enhanced ultrasound (CEUS) in reclassifying incidental renal findings categorized as indeterminate lesions (IL) or Bosniak ≥ 2F complex renal cysts (CRC) on CT or MRI.
Methods: We retrospectively included 44 subjects who underwent CEUS between 2016 and 2019 to assess 48 IL ( = 12) and CRC ( = 36) incidentally found on CT or MRI. CEUS was performed by one radiologist with 10 year of experience with a sulfur hexafluoride-filled microbubble contrast agent. The same radiologist, blinded to clinical information and previous CT/MRIs, retrospectively reviewed CEUS images/videos, categorizing renal findings with Bosniak-derived imaging categories ranging from 0 (indeterminate) to 5 (solid lesion). CEUS-related reclassification rate was calculated (proportion of IL reclassified with an imaging category >0, or CRC reclassified below or above imaging category >2F). Using histological examination or ≥ 24 months follow-up as the standard of reference, we also estimated per-lesion sensitivity/specificity for malignancy.
Results: CEUS reclassified 24/48 findings (50.0%; 95% C.I. 35.2-64.7), including 12/12 IL (100%; 95% CI 73.5-100) and 12/36 CRC (33.3%; 95% C.I. 18.5-50.9), mostly above category >2F (66.7%). CEUS and CT/MRI showed 96.0% (95%CI 79.7-99.9) 44.0% (95%CI 24.4-65.1) sensitivity, and 82.6% (95%CI 61.2-95.1) 60.9% (95%CI 38.5-80.3%) specificity.
Conclusion: CEUS provided substantial and accurate reclassification of CT/MRI incidental findings.
Advances In Knowledge: Previous studies included Bosniak 2 incidental findings, thus possibly underestimating CEUS-induced reclassification rates. Using a more meaningful cut-off (Bosniak ≥2F), problem-solving CEUS was effective as well, with higher reclassification rates for CRC than in literature.
He H, Jin X, Liu Y, Chen Y, Vaishnani D, Xia Y Abdom Radiol (NY). 2024; .
PMID: 39694945 DOI: 10.1007/s00261-024-04744-4.
Jin D, Zhuang B, Lin K, Zhang N, Qiao B, Xie X Insights Imaging. 2024; 15(1):285.
PMID: 39614021 PMC: 11607359. DOI: 10.1186/s13244-024-01858-7.
Richard P, Violette P, Bhindi B, Breau R, Gratton M, Jewett M Can Urol Assoc J. 2023; 17(6):162-174.
PMID: 37310905 PMC: 10263289. DOI: 10.5489/cuaj.8389.